Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors
The purpose of this international study is to try to predict which patients are more likely to have side effects from radiotherapy
Information
Our goal
The goal of the REQUITE project is to establish a multinational cohort of patients in order to validate known predictors and biomarkers of adverse reactions and late toxicity after radiotherapy and to eventually develop prediction models that can be useful when implemented in a clinical setting.
Our team
The REQUITE project is a collaborative multinational effort from multiple research institutions in eight different countries (Belgium, France, Germany, Italy, the Netherlands, Spain, UK, the USA).
The consortium is conformed by a multidisciplinary team, including epidemiologists, statisticians, radiation / clinical oncologists, biobank and database experts, research assistants, and patient advocates
Funding and current project coordination
The REQUITE project was funded by the European Commission, by ERA PerMed (RADprecise follow-up extension) and by the German Federal Office for Radiation Protection / BfS (REQUITEplus follow-up extension).
Although funding has formally ended, our partners at the University of Leicester have taken over the coordination of the project and biobank. The collected data and samples are currently being analyzed.
The REQUITE study 